Sign in Pull a receipt

TXG

10x Genomics, Inc.

Life Sciences Tools & Services · Life Sciences Tools & Services

$53.79 sample

-0.43 (-0.79%) 1D

Market cap

$34.7B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-23

Alerts

8

Price$53.79 +1.72% 3M daily closessample

54.9247.20

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23SEC8-K filed: material event
Oct 14INSInsider sell: 10% owner
Oct 05SECDEF 14A filed
Sep 29INSInsider sell: Chief Executive Officer
Sep 24INSInsider sell: Director
Sep 17INSInsider buy: 10% owner
Sep 14INSInsider sell: 10% owner
Sep 03INSInsider buy: 10% owner

Sign up to see the real TXG record →

Company facts

SEC EDGAR registration

Name: 10x Genomics, Inc.
Sector: Life Sciences Tools & Services
Industry: Life Sciences Tools & Services
Smart-money score: +5sample, -100 to +100
Reporting currency: USD

Who is positioning in TXG

sample

Insiders: 10 insider transactions over 90 days, net selling, $672.1M
Congress: No member trades over 90 days
Institutions · 13F: 7 funds hold $189.3M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.3B +13.1% y/y

Q4 2024Q3 2026

Inventory$1.4B +21.8% y/y

Q4 2024Q3 2026

Accounts receivable$1.0B +14.9% y/y

Q4 2024Q3 2026

Total debt$2.7B +7.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $30.6B -3.9% 3M
Sample peer B: $32.9B -2.6% 3M
Sample peer C: $25.9B -3.0% 3M
Sample peer D: $26.4B +4.0% 3M
Sample peer E: $9.4B -9.8% 3M